European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 0.57% to 1,657.92 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by brewing company Anheuser-Busch InBev (BUD) and lender Banco Santander (SAN), which advanced 2.3% and 1.5%, respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA) and biopharmaceutical company DBV Technologies (DBVT), which were up 0.7% and 0.5%, respectively.

The decliners from continental Europe were led by biopharmaceutical company argenx (ARGX) and biotech firm Evaxion (EVAX), which fell 4.9% and 4.4%, respectively. They were followed by internet advertising firm Criteo (CRTO) and Sequans Communications (SQNS), which were down 3.1% and 2.2%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which rose 14% and 3.7%, respectively. They were followed by lender Barclays (BCS) and insurance company Prudential (PUK), which were 2.6% and 2.4%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Amarin (AMRN) and software firm Endava (DAVA), which dropped 3% and 2.2%, respectively. They were followed by medical device maker Smith & Nephew (SNN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which increased 1.2% and 0.9%, respectively.